BioCryst Pharma, developing IV flu drug peramivir, plans to sell as many as 5.75M shares
BioCryst Pharma to sell up to 5.75M new shares Drug maker Novartis says lower dose of swine flu vaccine sufficient to guarantee immunity
Novartis: lower dose of flu vaccine sufficient AP POLL: Americans support taxing upper-income people to pay for health care overhaul more images Business foes of health care overhaul boost TV ads, other efforts as focus shifts to Senatemore images Beazer, Merck, Citigroup, Lowe’s, Apollo Group are among big market movers Monday
Beazer, Merck, Citigroup, Lowe’s are big movers Earnings roundup: Tween Brands posts 3Q profit, Perfect World profit surges 45 percent in 3Q
Earnings roundup: Tween Brands, Perfect World FDA questions missed study goals for Pfizer’s updated Prevnar vaccine for children
FDA reviews update to Pfizer vaccine for kids With Pfizer leaving, residents of Conn. city say fight over waterfront land was unnecessary
Pfizer move a new blow to Conn. city in land fight Poniard Pharma drops more than 70 percent after lung cancer drug fails in late stage trial
Poniard plunges on failure of picoplatin study Human Genome Sciences faces FDA regulatory delay on anthrax treatment
Human Genome sees FDA delay with anthrax treatment Genzyme says FDA holding off on Lumizyme approval, pending improvements at Boston facility
Genzyme’s Lumizyme faces delay over facility woes Par Pharma says FDA cleared 2 doses of its generic version of J&J’s pain drug Ultram ER
Par Pharma gets FDA approval for generic Ultram ER Poniard Pharma says picoplatin did not improve survival in late stage study; shares tumble
Poniard cancer drug misses goal in lung cancer Bristol-Myers splits off Mead Johnson, shareholders can swap Bristol shares for Mead stock
Bristol-Myers splits off Mead Johnson Nutrition Niacin shrinks artery plaque; Merck’s Zetia does not and may carry risks, new study finds
Study raises new questions about Merck pill Zetia Ex-residents of Conn. city Pfizer is leaving say fight over waterfront land was unnecessary
Conn. residents: Pfizer land battle unnecessary |
Topics
Latest TweetsHealth Care Industry
Latest Friend FeedsHealth Care Industry
|
